Amaral S, Matias A, Bouça B, Manique I, Palha A, Cortez L, Cerqueira L, Forte D, Sagarribay A, Dutra E, Cristóvão M, Pontinha C, Mafra M, Silva‐Nunes J. Pituitary metastasis as the first manifestation of lung carcinoma.
Clin Case Rep 2022;
10:e6601. [PMCID:
PMC9743320 DOI:
10.1002/ccr3.6601]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Revised: 10/14/2022] [Accepted: 10/30/2022] [Indexed: 12/14/2022] Open
Abstract
Pituitary metastases are rare. Clinical presentation could range from asymptomatic to panhypopituitarism or local symptoms. We present a case report of a 43‐year‐old male patient with a new onset headache, visual disturbances, and panhypopituitarism. The investigation led to the diagnosis of pituitary metastasis as the first manifestation of underlying lung cancer.
With rising incidence of breast and lung malignancy, headache/visual field disturbance or signs of pituitary hormone deficiency might be the presenting feature of pituitary metastatic disease. A rapid growth of a sellar lesion and/or the presence of diabetes insipidus along with a sellar mass should raise the suspicion for malignancy.
Collapse